Annual Working Capital
$125.43 M
+$23.63 M+23.21%
December 31, 2021
Summary
- As of February 7, 2025, AMYT annual working capital is $125.43 million, with the most recent change of +$23.63 million (+23.21%) on December 31, 2021.
- During the last 3 years, AMYT annual working capital has risen by +$118.18 million (+1630.79%).
Performance
AMYT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$81.30 M
-$33.01 M-28.88%
September 30, 2022
Summary
- As of February 7, 2025, AMYT quarterly working capital is $81.30 million, with the most recent change of -$33.01 million (-28.88%) on September 30, 2022.
- Over the past year, AMYT quarterly working capital has dropped by -$41.66 million (-33.88%).
Performance
AMYT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AMYT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.2% | -33.9% |
| 3 y3 years | +1630.8% | - |
| 5 y5 years | +532.7% | +310.1% |
AMYT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -35.4% | at low |
| 5 y | 5-year | at high | -53.4% | -35.4% | -65.3% |
| alltime | all time | at high | -100.0% | -35.4% | -100.1% |
Amryt Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $81.30 M(-28.9%) |
| Jun 2022 | - | $114.32 M(-9.2%) |
| Mar 2022 | - | $125.94 M(+0.4%) |
| Dec 2021 | $125.43 M(+23.2%) | $125.43 M(+2.0%) |
| Sep 2021 | - | $122.97 M(+1.3%) |
| Jun 2021 | - | $121.39 M(+12.7%) |
| Mar 2021 | - | $107.73 M(+5.8%) |
| Dec 2020 | $101.80 M(+74.0%) | $101.80 M(+114.0%) |
| Sep 2020 | - | $47.57 M(+68.5%) |
| Jun 2020 | - | $28.24 M(-10.2%) |
| Mar 2020 | - | $31.44 M(-46.3%) |
| Dec 2019 | $58.50 M(+707.3%) | $58.50 M(<-9900.0%) |
| Jun 2019 | - | -$105.70 K(-101.5%) |
| Dec 2018 | $7.25 M | $7.25 M(-38.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $11.70 M(-41.0%) |
| Dec 2017 | $19.83 M(+134.7%) | $19.83 M(+37.6%) |
| Jun 2017 | - | $14.40 M(+70.5%) |
| Dec 2016 | $8.45 M(-38.0%) | $8.45 M(-36.1%) |
| Jun 2016 | - | $13.22 M(-12.0%) |
| Dec 2015 | $13.62 M(-15.6%) | - |
| Sep 2015 | - | $15.03 M(-6.8%) |
| Mar 2015 | $16.13 M(+269.6%) | $16.13 M(-12.8%) |
| Sep 2014 | - | $18.50 M(+323.9%) |
| Mar 2014 | $4.36 M(-85.9%) | $4.36 M(-56.9%) |
| Sep 2013 | - | $10.12 M(-67.3%) |
| Mar 2013 | $30.97 M(+2942.0%) | $30.97 M(+2942.0%) |
| Mar 2012 | $1.02 M(-2976.3%) | $1.02 M(-2976.3%) |
| Mar 2011 | -$35.40 K(-9.7%) | -$35.40 K(-9.7%) |
| Mar 2010 | -$39.20 K | -$39.20 K |
FAQ
- What is Amryt Pharma annual working capital?
- What is the all time high annual working capital for Amryt Pharma?
- What is Amryt Pharma annual working capital year-on-year change?
- What is Amryt Pharma quarterly working capital?
- What is the all time high quarterly working capital for Amryt Pharma?
- What is Amryt Pharma quarterly working capital year-on-year change?
What is Amryt Pharma annual working capital?
The current annual working capital of AMYT is $125.43 M
What is the all time high annual working capital for Amryt Pharma?
Amryt Pharma all-time high annual working capital is $125.43 M
What is Amryt Pharma annual working capital year-on-year change?
Over the past year, AMYT annual working capital has changed by +$23.63 M (+23.21%)
What is Amryt Pharma quarterly working capital?
The current quarterly working capital of AMYT is $81.30 M
What is the all time high quarterly working capital for Amryt Pharma?
Amryt Pharma all-time high quarterly working capital is $125.94 M
What is Amryt Pharma quarterly working capital year-on-year change?
Over the past year, AMYT quarterly working capital has changed by -$41.66 M (-33.88%)